Toronto, Ontario - April 17, 2014 - Vida Cannabis Corp. ("Vida Cannabis") is pleased to announce that Quantum 9 Inc. has been retained to provide consulting, technology and implementation services. Quantum 9 (www.quantum9.net) is North America`s pre-eminent authority on cannabis cultivation consulting and technology services, with extensive experience in working with Health Canada`s Marihuana for Medical Purposes Regulations ("MMPR").
The Quantum 9 team is comprised of experts in the critical areas of security, quality assurance, the producer licensing process, facility design and maximizing production yields. They are a proven `blueprint-to-harvest` service provider to several large-scale medical and recreational marijuana companies in the United States, Canada and Europe.
Vida Cannabis CEO Greg Wilson stated: "I look forward to working with Michael Mayes and the Quantum 9 team on finalizing our MMPR application, and in designing a state-of-the-art production facility that will be nearly twice the size of any currently licensed producer in Canada. Quantum 9`s experience in assisting with the administrative process of licensure applications will be extremely valuable in completing this integral step. Our retainer of Quantum 9 is yet another example of Vida`s forward-looking, high quality stewardship, which shareholders should continue to expect from the Company."
Quantum 9 has been on location in Stellarton and personnel are in the process of finalizing the security and facility design to optimize the build-out of Vida`s 315,000-square-foot facility, including an initial production area of approximately 30,000 square feet, with a roadmap for expansion driven by market demand.
Michael Mayes, CEO of Quantum 9, stated: "We are very excited about our partnership with Vida Cannabis. Their executive staff rivals that of the best we have seen in the industry and we are excited to bring our expert experience to ensure a best-in-class operation."
CEO Greg Wilson continued: "We are well underway with our application, and expect to submit it to Health Canada in the next four weeks. In addition, I met with our security consultant, Derek Ogden, a senior executive with 27 years service with the RCMP, on-site this week to finalize the minimum level-9 security plan and start work on its implementation. Security is a top priority for Vida, and it is our intention to build our facility to standards that exceed the requirements set out by Health Canada. In some areas of security design we will be implementing level 10 and 11 measures."
About Vida Cannabis Corp.
About Vida Cannabis
Vida Cannabis Corp. ("Vida Cannabis") is focused on developing a dominant production footprint in the rapidly developing global marketplace for the legal use of medicinal and recreational marijuana.
Initial operations are focused on the Canadian market where Health Canada has established national guidelines enabling best-in-class producers to acquire commercial production licenses under the Marihuana for Medical Purposes Regulations.
Via its wholly owned subsidiary, Vida Cannabis (Canada) Ltd., Vida Cannabis purchased a 315,000-square-foot production facility in the town of Stellarton, Nova Scotia and secured a 50-year irrevocable approval unanimously from the local municipality to operate a medical marijuana production plant at the facility.
The highly secure facility boasts a fully engineered concrete floor, 18-foot-high concrete walls and a steel roof making it an ideal location for the construction of a customized, state-of-the-art modern medical marijuana production plant.
Vida Cannabis is working with one of the most talented cannabis consulting teams in the world, Quantum 9 Inc., which has extensive resources in the United States, Canada and Europe, to establish an optimized end-to-end production plan to help position Vida Cannabis with the largest, most advanced medical marijuana facility in Canada.
Vida Cannabis continues to evaluate additional potential markets as regulatory bodies around the world pass legislation enabling the production and distribution of medicinal or recreational marijuana.
About Quantum 9
Quantum 9 provides sustainable solutions for the cannabis industry using horticultural process management making efficient use of scarce natural resources like water and energy. Through implementing cultivation automation, technology, and business process optimization, companies scale to more profitable farming, effectively improving quality and yield to meet growing demand. The Quantum 9 staff includes some of the most brilliant minds in the field with a focus on helping organizations evolve from market gardening to industrial horticulture.
Quantum 9 offers Marijuana for Medical Purposes Regulations (MMPR) production license preparation documentation and consulting services. The Quantum 9 team helps clients drive the process from blueprint to harvest, with over 30 years of experience in cultivating and perfecting our delivery planning.
Quantum 9 staffs Engineers, Architects, General Contractors, Horticulturists, Botanist and Plant Nutritionist with expert level experience that will help develop an enterprise project plan that take into account pest and pathogen protection ensuring the cultivation of high grade medicine. Consulting areas include, for example: Architectural Blueprinting; HVAC, Electrical, Plumbing; Room Layout Space Optimization; Security Planning; General Contractor Acquisition; Wholesale Equipment Acquisition; Laboratory Testing Assignment; Reverse Traceability Technology; Plant Health Optimization; Production Optimization.
To learn more about Quantum 9, visit their website - www.quantum9.net.
On behalf of the board,
Greg Wilson - Director & CEO
Vida Cannabis Corp.
This announcement does not constitute or form part of, and shall under no circumstances be considered as, an offer to sell, a solicitation to purchase, or advice on investments in any securities of Vida Cannabis Corp. ("Vida Cannabis"). Offers and solicitations shall be expressly identified as such and made in compliance with applicable securities laws. This announcement is for information purposes only. It should not be relied upon as a basis for investment decisions. You should consult with your own investment, accounting, legal and tax advisers to evaluate independently the risks, consequences and suitability of any investments you are considering. Whilst the information provided here is believed to be reliable, it cannot be guaranteed. It may contain forward-looking statements made by or on behalf of Vida Cannabis about its business or financial objectives, position, strategies or expectations. Such forward-looking statements may be identified by words such as, or similar to, "intends," "anticipates," "believes," "expects" and "hopes" and includes, without limitation, the development of production facilities, approval from regulatory authorities and the ability for Vida Cannabis to obtain adequate financing to meet its business objectives. These statements involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated. The statements in this announcement do not guarantee future performance. Vida Cannabis does not undertake any obligation to update any information provided in this announcement. In Canada, Vida Cannabis (Canada) Ltd., a wholly owned subsidiary of Vida Cannabis, must obtain approval from Health Canada in order to operate as a licensed commercial producer under the Marihuana for Medical Purposes Regulations. Vida Cannabis makes no representations or warranties that it will receive Health Canada approval.
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Vida Cannabis Corp. via GlobeNewswire